Koninklijke Philips (PHG) Net Cash Flow Growth (3y) (2012 - 2026)

Koninklijke Philips (PHG) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Abbott Laboratories 181.33 Bn 174.04 Bn 6.27 Bn -32.51%
2 Stryker 128.11 Bn 125.23 Bn 3.81 Bn -87.87%
3 Medtronic 107.76 Bn 98.54 Bn 6.41 Bn 31.32%
4 Boston Scientific 67.95 Bn 66.50 Bn 3.61 Bn -11.49%
5 Edwards Lifesciences 47.64 Bn 43.97 Bn 1.29 Bn -87.88%
6 GE HealthCare Technologies 28.43 Bn 26.14 Bn 1.98 Bn -65.12%
7 Dexcom 28.31 Bn 27.20 Bn 750.30 Mn 129.29%
8 Smith & Nephew 26.77 Bn 26.19 Bn - -
9 Koninklijke Philips 25.33 Bn 22.21 Bn 2.07 Bn -48.90%
10 Steris 21.41 Bn 20.97 Bn 697.10 Mn 33.47%

Historic Data

Download Data
DateValue
Mar 31, 2026 -48.90%
Dec 31, 2025 30.61%
Sep 30, 2025 50.15%
Jun 30, 2025 42.61%
Mar 31, 2025 -67.49%
Dec 31, 2024 27.26%
Sep 30, 2024 -60.60%
Jun 30, 2024 27.55%
Mar 31, 2024 -49.12%
Dec 31, 2023 -79.03%
Sep 30, 2023 -7.46%
Jun 30, 2023 -37.41%
Mar 31, 2023 2.76%
Dec 31, 2022 -86.20%
Sep 30, 2022 -34.96%
Jun 30, 2022 -8.62%
Mar 31, 2022 -162.12%
Dec 31, 2021 -56.52%
Sep 30, 2021 -0.69%
Jun 30, 2021 -39.68%